Correlation of long non-coding RNA H19 expression with cisplatin-resistance and clinical outcome in lung adenocarcinoma

The acquired drug resistance would influence the efficacy of cisplatin-based chemotherapy in non-small-cell lung cancer. The present study aimed to investigate the correlation of long non-coding RNA (lncRNA) H19 with cisplatin-resistance and clinical outcome in lung adenocarcinoma. In our study, the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Oncotarget 2017-01, Vol.8 (2), p.2558-2567
Hauptverfasser:	Wang, Qi, Cheng, Ningning, Li, Xuefei, Pan, Hui, Li, Chunyu, Ren, Shengxiang, Su, Chunxia, Cai, Weijing, Zhao, Chao, Zhang, Limin, Zhou, Caicun
Format:	Artikel
Sprache:	eng
Schlagworte:	A549 Cells Adenocarcinoma - genetics Adenocarcinoma - pathology Adenocarcinoma of Lung Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Cell Line, Tumor Cisplatin - pharmacology Cisplatin - therapeutic use Drug Resistance, Neoplasm Female Gene Expression Regulation, Neoplastic Humans Lung Neoplasms - genetics Lung Neoplasms - pathology Male Neoplasm Metastasis Neoplasm Staging Research Paper RNA, Long Noncoding - genetics Up-Regulation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!